Dimethyl fumarate Teva Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Sendoxan Tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan tafla 50 mg

baxter medical ab* - cyclophosphamidum inn - tafla - 50 mg

Sendoxan Stungulyfsstofn, lausn 1 g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan stungulyfsstofn, lausn 1 g

baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 1 g

Sendoxan Stungulyfsstofn, lausn 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan stungulyfsstofn, lausn 500 mg

baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 500 mg

Holoxan Innrennslisstofn, lausn 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

holoxan innrennslisstofn, lausn 500 mg

baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 500 mg

Holoxan Innrennslisstofn, lausn 2000 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

holoxan innrennslisstofn, lausn 2000 mg

baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 2000 mg

Holoxan Innrennslisstofn, lausn 1000 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

holoxan innrennslisstofn, lausn 1000 mg

baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 1000 mg

Aubagio Evrópusambandið - íslenska - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomide - margvísleg sclerosis - valdar ónæmisbælandi lyf - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Teriflunomide Mylan Evrópusambandið - íslenska - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).